Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RETRACTION
Retraction: Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis
Oncology Research 2025, 33(6), 1509-1509. https://doi.org/10.32604/or.2024.062048
Issue published 29 May 2025
This article is a retraction of:
Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis
Read original article
View Full Text
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Office, O.R.E. (2025). Retraction: Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. Oncology Research, 33(6), 1509–1509. https://doi.org/10.32604/or.2024.062048
Vancouver Style
Office ORE. Retraction: Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis. Oncol Res. 2025;33(6):1509–1509. https://doi.org/10.32604/or.2024.062048
IEEE Style
O.R.E. Office, “Retraction: Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis,” Oncol. Res., vol. 33, no. 6, pp. 1509–1509, 2025. https://doi.org/10.32604/or.2024.062048
Copyright © 2025 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
